Jyong Biotech Ltd. Ordina...

NASDAQ: MENS · Real-Time Price · USD
43.16
-4.49 (-9.42%)
At close: Aug 21, 2025, 3:59 PM
43.72
1.30%
After-hours: Aug 21, 2025, 07:47 PM EDT

Jyong Biotech Ordinary Shares Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-3.02M -4.4M -6.63M -4.2M
Depreciation & Amortization
120K 127K 123K 122K
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-1.49M 1.12M 2.96M 1.22M
Other Non-Cash Items
761K 554K 599K 849K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.49M 1.12M 2.94M 1.24M
Operating Cash Flow
-3.62M -2.6M -2.97M -1.98M
Capital Expenditures
n/a n/a -246K -137K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -292K -1.83M
Sales Maturities Of Investments
n/a 95K 1.93M 664K
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a 95K 1.39M -1.31M
Debt Repayment
2.2M 2.47M 3.61M -1.35M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-213K -445K -276K -35K
Financial Cash Flow
1.99M 2.03M 3.33M -1.38M
Net Cash Flow
-1.64M -532K 1.72M -4.61M
Free Cash Flow
-3.62M -2.6M -3.22M -2.12M